A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER. A-JMRHS [Internet]. 2026 Feb. 20 [cited 2026 Feb. 28];4(01):203-8. Available from: https://www.ajmrhs.com/journal/article/view/42